Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 深圳诺普信作物科学股份有限公司(以下简称“公司”),于 1999 年 9 月成立,2008年A股上市(股票代码 002215)),现注册资本为 9.83亿元,是一家以研发、生产、销售农业投入品(主要是农药制剂和植物营养)并提供专业化综合农业服务的国家级高新技术企业,深圳市政府认定的总部企业、宝安区先驱性企业、宝安区战略新兴百强企业,国家知识产权优势企业、广东省重点农业龙头企业、广东省民营百强企业。2019 年被农业农村部农民日报社评为“2018 中国三农创新十大榜样”之一(系唯一当选企业,其余九大榜样均为政府部门),公司致力于植物保护及品质农业的产业链经营,致力于广大农民的增收致富,致力于保障农产品安全,促进环境改善和生态保护,从而成长为中国优秀的作物专业服务公司。 经过多年的创新变革与探索实践,公司已逐步形成了“农资研产销、农业综合服务与特色作物产业链”三大战略三块业务齐头并进的发展新格局。一是继续发扬工匠精神打磨研制高品质的农药制剂、植物营养等产品,使其保持全国的领先地位,并整合全球优质资源,多方位地满足农业种植的市场需求;二是面向各地渠道与优秀经销商深度融合,持续不断地向区域平台全方位赋能,打造出一个个区域性领先的农业综合服务平台,三是积极探索单一特色作物产业链经营,通过打造单一作物产业链模式,来引领中国农业一个个作物产业链达到世界一流水平。公司还设立了“特色作物产业科技研究院”、“致良知农学院”配称支撑特色作物产业链的科研和新农人培训,并通过公司较为成熟的“产业科技示范园”模式将选定的特色作物逐一落地实施。 诺普信长期扎根农村,服务三农,专注三农,立足于农药制剂业务,强化农业服务本地化。公司多年来深耕农业种植领域、生物技术及化学化工行业,聚集了众多行业顶尖人才和积累了深厚的技术资源和宝贵经验,现赋能于作物产业链的发展,既可帮助农民增收致富,又可推动产业扶贫和乡村振兴,切实符合公司三大战略同步发展。 公司拥有“诺普信”“瑞德丰”“标正”等多个全国性品牌,和“中国驰名商标”。诺普信连续多年位列中国农药制剂行业销量排行榜前列,连续 8 年被农民日报社评为“中国农民喜爱的农药企业品牌”,成为中国农业生产性服务业联盟理事长单位。诺普信始终秉承“全心全意为农民服务”之心,将“创建中国遥遥领先的单一作物技术服务平台”作为企业愿景,全面践行“以一流的产品和服务为农户创造关键价值”的企业价值观,全面推动“一个大品/方案-技术服务品牌战略”,为实现“农业不再落后,农民无比幸福”的伟大使命而奋斗不息。 诺普信现有员工近3500人(含子公司),公司整体经营业绩保持了持续增长,营业总收入2022年实现营业总收入42.65亿元,归母净利润为3.28亿元,公司净资产36.68亿元,总资产97.94亿元。 | ||||||||||||||||||||||||
Main Business | 农药制剂产品的研发、生产、销售及植保技术服务。 | ||||||||||||||||||||||||
Legal Representative | 高焕森 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 莫谋钧 | ||||||||||||||||||||||||
Solicitors | 北京市君泽君律师事务所 | ||||||||||||||||||||||||
Auditors | 大华会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 0755-29977586 | ||||||||||||||||||||||||
Fax No | 0755-27697715 | ||||||||||||||||||||||||
Website | www.noposion.com | ||||||||||||||||||||||||
npx002215@126.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 18/02/2008 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 0.241 | ||||||||||||||||||||||||
DPS(RMB)* | ¥ 0.150 | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 3.769 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 9.298B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |